Amarin Corp Plcuk (AMRN) Non-Current Debt (2010 - 2019)

Amarin Corp Plcuk (AMRN) reported Non-Current Debt of $8.9 million for Q3 2019, down 69.55% year-over-year from $29.2 million in Q3 2018, and down 61.74% quarter-over-quarter from $23.2 million in Q2 2019.

Amarin Corp Plcuk (AMRN) Non-Current Debt (2010 - 2019) Analysis & Trends

Amarin Corp Plcuk (AMRN) has 10 years of Non-Current Debt data on file, last reported at $8.9 million in Q3 2019.

  • Non-Current Debt for Q3 2019 came in at $8.9 million, down 69.55% year-over-year; the trailing twelve-month figure through Sep 2019 was $8.9 million (down 69.55% YoY), and the FY2018 annual result was $46.1 million, up 59.04% from the prior year.
  • Non-Current Debt fell to $8.9 million in Q3 2019 per AMRN's latest filing, from $23.2 million in the prior quarter.
  • Over five years, Non-Current Debt peaked at $136.7 million in Q4 2015 and troughed at $8.9 million in Q3 2019.
  • A 5-year average of $64.7 million and a median of $62.7 million in 2017 frame the typical range for Non-Current Debt.
  • The sharpest annual moves came in 2018 and 2019: Non-Current Debt jumped 59.04% in 2018, then tumbled 69.55% in 2019.
  • A 5-year view of Non-Current Debt shows it stood at $136.7 million in 2015, then slumped by 37.72% to $85.2 million in 2016, then plunged by 65.95% to $29.0 million in 2017, then jumped by 59.04% to $46.1 million in 2018, then plunged by 80.75% to $8.9 million in 2019.
  • Business Quant data shows AMRN's Non-Current Debt at $8.9 million in Q3 2019, $23.2 million in Q2 2019, and $35.3 million in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -18.89 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 39.37 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 37.53 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 64.53 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 46.67 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 51.89 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 20.86 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 60.57 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 42.15 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2019 8.88 Mn
Sep 30, 2019 8.88 Mn
Jun 30, 2019 23.20 Mn
Jun 30, 2019 23.20 Mn
Mar 31, 2019 35.34 Mn
Mar 31, 2019 35.34 Mn
Dec 31, 2018 46.11 Mn
Dec 31, 2018 46.11 Mn
Sep 30, 2018 29.16 Mn
Sep 30, 2018 29.16 Mn
Jun 30, 2018 29.10 Mn
Jun 30, 2018 29.10 Mn
Mar 31, 2018 29.05 Mn
Mar 31, 2018 29.05 Mn
Dec 31, 2017 28.99 Mn
Dec 31, 2017 28.99 Mn
Sep 30, 2017 28.94 Mn
Sep 30, 2017 28.94 Mn
Jun 30, 2017 79.28 Mn
Jun 30, 2017 79.28 Mn